PREVIEW the webinar recording here (Join ASBD NowWATCH the recorded webinar

image description

Date:        Tuesday 20 May 2025
Time:        7:00 PM AEST (Sydney) 

Cost:         FREE (Members and Non-Members)  

Note: The recording of this webinar will be available to ASBD members in the coming days

This webinar is a must for all clinicians and allied health on what is happening now and in the future with  radiotherapy and with its integration in the multidisciplinary care of our patients. 

It will demonstrate how modern radiotherapy has moved with surgical and systemic therapies to optimise care for our patients highlighting the advances in technical delivery and radiobiological modelling that has improved care. We will also discuss what modern radiotherapy side effects commonly look like with contemporary fractionation with proactive strategies to manage. The webinar will also focus on current clinical conundrums and discuss ways to navigate and what clinical trials are open to address these. 

Chaired by: 

  • Dr Angela Allen

 

Dr Angela Allen is a consultant Radiation Oncologist at the Royal Brisbane and Women's Hospital, and Mater Cancer Care Centre Springfield.Dr Allen graduated with a Bachelor of Science (Hons) at The University of California at Santa Barbara in 2002. She completed her medical degree with Honours at The University of Queensland in 2006. She undertook specialist training in Radiation Oncology at the Peter MacCallum Cancer Centre in Melbourne, Victoria and was awarded fellowship to the Royal Australian and New Zealand College of Radiologists (FRANZCR) in 2014.

 

Speakers:

Dr Gabrielle Metz - - Radiation Oncologist , Current BCT fellow award recipient

Dr Gabrielle Metz is a radiation oncologist and 2025 clinical fellow with Breast Cancer Trials. Her project, optimising radiotherapy in the neoadjuvant therapy era, also known as ORNATE, aims to refine radiotherapy for breast cancer patients receiving chemotherapy before surgery.

By creating a multicentre database, researchers can explore whether radiation doses can be safely reduced, and assess less invasive lymph node treatments, all while considering patient experiences and outcomes. We spoke with her about the importance of this research and what it means for patients.

“There’s been a current trend to increase the utility of neoadjuvant therapy for breast cancer patients. And most of these patients do end up having adjuvant radiotherapy after their surgery. But all of our data to support radiotherapy for breast cancer patients is pre the neoadjuvant era.”

“We don’t actually have good, robust, long-term data that supports or can guide radiotherapy in this particular patient cohort. There has been some recent data that looks at de-escalating treatment or radiotherapy in patients who have an excellent response to neoadjuvant therapy, but the follow-ups are not long enough.”

“I wanted to create a registry that captures local women, and local trends in practice where we can possibly have one area where all of their data is collected, and analyse their outcomes, particularly in relation to what radiotherapy they received. We then want to look at reducing the amount of radiation that they’re getting.”

 

A/Prof Gillian Lamoury -  Breast Radiation Oncologist

A/Prof Gillian Lamoury is a specialist Radiation Oncologist at Royal North Shore Hospital, and VMO at the Mater Hospital, with a sub-speciality interest in the treatment of breast cancer.

She is the recent past Chair of the Breast Cancer Advisory Group (Cancer Australia 2018 -2020) and was inaugural Chair of BIG-FRO (2014), the Breast Interest Group- Faculty of Radiation Oncology.

She is a member of the Strategic Advisory Group for Breast Cancer Network Australia (BCNA), with a passion for patient advocacy, and equitable access to best oncological care.

Gillian is Clinical Associate Professor at the University of Sydney, and keenly involved in education, teaching and research. She is Principal Investigator on several International, national and Investigator-led trials at Royal North Shore and the Mater Hospital.

 

 A/Prof Susan Carroll - Radiation Oncologist

A/Prof Susan Carroll is a Senior Radiation Oncologist who sub-specialises in breast cancer, haematological malignancies and lower gastrointestinal cancers. She is a Clinical Associate Professor in Radiation Oncology for Sydney University.

She did her undergraduate degree at University of NSW and her Specialist training at Prince of Wales 0ospital, Sydney where she subsequently worked for 7 years as a Radiation Oncologist subspecialising in haematology, paediatric and breast cancer. She then moved to Royal Prince Alfred Hospital for over a decade and now works at Royal North Shore Hospital as a senior staff specialist and a visiting Radiation Oncologist for GenesisCare.

A/Prof Susan Carroll is a Senior Radiation Oncologist who sub-specialises in breast cancer, haematological malignancies and lower gastrointestinal cancers. She is a Clinical Associate Professor in Radiation Oncology for Sydney University.

She did her undergraduate degree at University of NSW and her Specialist training at Prince of Wales 0ospital, Sydney where she subsequently worked for 7 years as a Radiation Oncologist subspecialising in haematology, paediatric and breast cancer. She then moved to Royal Prince Alfred Hospital for over a decade and now works at Royal North Shore Hospital as a senior staff specialist and a visiting Radiation Oncologist for GenesisCare.

🔹 Followed by:

Case-based presentations and panel discussion

WATCH PREVIOUS WEBINARS HERE

The ASBD  launched a new monthly 2025 Rapid-Fire Update Webinar Series on 8th April 2025.

These concise, topical case-based webinars of approximately 1 hour are aimed at busy members of the multidisciplinary breast cancer team.